Astrazeneca Share News (AZN)

LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals

(Alliance News) - Stocks in London are set to open higher on Wednesday as UK markets returned to business following the Christmas break.

European shares rise tentatively

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

AstraZeneca wins two new approvals in EU for cancer drugs

(Alliance News) - AstraZeneca PLC on Wednesday said it won two new drug approvals in the European Union for Imfinzi and Lynparza to treat cancer.

LONDON MARKET OPEN: European markets make gains in early trade

(Alliance News) - Stock prices in London opened higher on Wednesday, while official statistics showed a surge in UK government borrowing, as Westminster forks out billions for its energy support scheme.

LONDON BRIEFING: UK public sector borrowing shoots up in November

(Alliance News) - Stock prices in London were called to open higher on Wednesday, after a positive finish on Wall Street.

AstraZeneca wins EU backing for heart drug, but suffers lung cancer setback

Dec 19 (Reuters) - AstraZeneca on Monday won European endorsement for its blockbuster drug, dapagliflozin, as a treatment for all forms of heart failure, the company said.

TOP NEWS: AstraZeneca receives host of EU approvals or recommendations

(Alliance News) - AstraZeneca PLC on Monday said it received a host of approvals or recommendations for approval for a handful of prospective treatments in the EU, but noted disappointing phase 3 trial results for Imfinzi.

LONDON MARKET OPEN: Stocks higher as China begins shaky reopening

(Alliance News) - Stock prices in London opened higher on Monday, but the FTSE 100 was lagging behind European counterparts, despite gains for oil and mining stocks.

AstraZeneca's Imfinzi plus Imjudo recommended for EU approval

(Sharecast News) - AstraZeneca said on Monday that its Imfinzi (durvalumab) and Imjudo (tremelimumab) combinations have been recommended for marketing authorisation in the European Union for advanced liver and lung cancers.

LONDON BRIEFING: Stocks called up, but prospect of Santa rally fades

(Alliance News) - The FTSE 100 index looked set to regain some lost ground early on Monday, having fallen to a four-week low last week.

AstraZeneca's Forziga recommended for EU use

(Sharecast News) - AstraZeneca's Forxiga drug has been recommended for approval in the EU for symptomatic chronic heart failure, the pharma company said on Monday.

European shares post worst weekly loss since September as recession fears mount

STOXX 600 drops 3.3% this week

*

HealthBeacon appoints new interim CFO, permanent CFO process ongoing

(Alliance News) - HealthBeacon PLC on Friday said it appointed a new interim chief financial officer, while the process to appoint a CFO on a permanent basis is ongoing.

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership

(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner programme with AstraZeneca PLC.

LONDON BROKER RATINGS: Goldman Sachs likes Big Yellow, Great Portland

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: